Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Labiano

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Oncoimmunology|January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse modelAizea Morales-Kastresana, Miguel F Sanmamed, Inmaculada Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2021
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck TumorsSara Labiano, Vincent Roh, Céline Godfroid, et al.
Journal for Immunotherapy of Cancer|January 23, 2025
PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironmentCéline Godfroid, Jackeline Romero, Sara Labiano, et al.
JCI Insight|August 15, 2024
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma modelsIker Ausejo-Mauleon, Naiara Martinez-Velez, Andrea Lacalle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal AntibodiesArantza Azpilikueta, Jackeline Agorreta, Sara Labiano, et al.
Oncoimmunology|March 5, 2016
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanismSara Labiano, Asis Palazón, Elixabet Bolaños, et al.
Oncoimmunology|November 21, 2015
Functional expression of CD137 (4-1BB) on T helper follicular cellsCarlos Alfaro, Jose I Echeveste, Maria E Rodriguez-Ruiz, et al.
Cancer Research|October 10, 2018
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-PrimingAlfonso R Sánchez-Paulete, Álvaro Teijeira, José I Quetglas, et al.
Molecular Cancer Therapeutics|December 30, 2021
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune MemoryNaiara Martinez-Velez, Virginia Laspidea, Marta Zalacain, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Oncoimmunology|January 4, 2018
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB)Arantza Azpilikueta, Elixabet Bolaños, Valerie Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2013
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse modelAizea Morales-Kastresana, Miguel F Sanmamed, Inmaculada Rodriguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2021
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck TumorsSara Labiano, Vincent Roh, Céline Godfroid, et al.
Journal for Immunotherapy of Cancer|January 23, 2025
PD-1 cis-targeted IL-2v in combination with radiotherapy inhibits lung cancer growth and remodels the immune microenvironmentCéline Godfroid, Jackeline Romero, Sara Labiano, et al.
JCI Insight|August 15, 2024
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma modelsIker Ausejo-Mauleon, Naiara Martinez-Velez, Andrea Lacalle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2016
Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal AntibodiesArantza Azpilikueta, Jackeline Agorreta, Sara Labiano, et al.
Oncoimmunology|March 5, 2016
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanismSara Labiano, Asis Palazón, Elixabet Bolaños, et al.
Oncoimmunology|November 21, 2015
Functional expression of CD137 (4-1BB) on T helper follicular cellsCarlos Alfaro, Jose I Echeveste, Maria E Rodriguez-Ruiz, et al.
Cancer Research|October 10, 2018
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-PrimingAlfonso R Sánchez-Paulete, Álvaro Teijeira, José I Quetglas, et al.
Molecular Cancer Therapeutics|December 30, 2021
Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune MemoryNaiara Martinez-Velez, Virginia Laspidea, Marta Zalacain, et al.
Pageof 5